Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer.

MLA

Ito, Mayuko, et al. “Impact of Circulating Tumour Cells on Survival of Eribulin-Treated Patients with Metastatic Breast Cancer.” Medical Oncology (Northwood, London, England), vol. 36, no. 10, Sept. 2019, p. 89. EBSCOhost, https://doi.org/10.1007/s12032-019-1314-9.

APA

Ito, M., Horimoto, Y., Tokuda, E., Murakami, F., Uomori, T., Himuro, T., Nakai, K., Orihata, G., Iijima, K., & Saito, M. (2019). Impact of circulating tumour cells on survival of eribulin-treated patients with metastatic breast cancer. Medical Oncology (Northwood, London, England), 36(10), 89. https://doi.org/10.1007/s12032-019-1314-9

Chicago

Ito, Mayuko, Yoshiya Horimoto, Emi Tokuda, Fumi Murakami, Toshitaka Uomori, Takanori Himuro, Katsuya Nakai, Gotaro Orihata, Kotaro Iijima, and Mitsue Saito. 2019. “Impact of Circulating Tumour Cells on Survival of Eribulin-Treated Patients with Metastatic Breast Cancer.” Medical Oncology (Northwood, London, England) 36 (10): 89. doi:10.1007/s12032-019-1314-9.